Security key
92532F100
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,406,089
- Total 13F shares
- 231,885,243
- Share change
- -3,549,652
- Total reported value
- $103,502,349,347
- Put/Call ratio
- 78%
- Price per share
- $446.54
- Number of holders
- 1,663
- Value change
- -$1,636,333,502
- Number of buys
- 796
- Number of sells
- 688
Report period
Q1 2026
Institutions
1,663
Top holders
10
VRTX full security history
Previous quarter: Q4 2025
VERTEX PHARMACEUTICALS INC / MA SEC filings
VERTEX PHARMACEUTICALS INC / MA company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92532F100
Recent filing periods:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
13D/G
|
Company |
10%
from 13D/G
|
25,510,182
|
$11,565,309,006 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.5%
|
24,105,823
|
$10,928,615,915 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
9.3%
|
23,751,989
|
$10,768,201,653 | — | 31 Dec 2025 | |
| Capital Research Global Investors |
13D/G
13F
|
Company |
8.3%
|
21,139,169
|
$9,129,161,524 | +$1,649,759,182 | 31 Mar 2026 | |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
|
Vanguard Capital Management |
7.5%
|
19,036,076
|
$8,500,369,377 | $0 | 31 Mar 2026 | |
| STATE STREET CORP |
13F
|
Company |
4.6%
|
11,689,539
|
$5,299,569,401 | — | 31 Dec 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
3.6%
|
9,220,827
|
$4,642,686,284 | $0 | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.4%
|
6,039,481
|
$2,738,059,237 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
5,981,905
|
$2,700,207,827 | — | 31 Dec 2025 | |
| Capital International Investors |
13F
|
Company |
1.9%
|
4,733,596
|
$2,146,040,530 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.8%
|
4,496,482
|
$2,038,525,080 | — | 31 Dec 2025 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.6%
|
4,033,525
|
$1,828,638,685 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.5%
|
3,821,731
|
$1,732,619,966 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1.3%
|
3,356,766
|
$1,521,850,963 | — | 31 Dec 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.3%
|
3,249,541
|
$1,473,211,801 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.2%
|
3,176,613
|
$1,440,149,270 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
3,120,310
|
$1,414,625,263 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
3,000,778
|
$1,360,432,714 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
1.2%
|
2,937,030
|
$1,331,532,113 | — | 31 Dec 2025 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.1%
|
2,860,176
|
$1,296,689,269 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
2,579,457
|
$1,169,422,624 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.9%
|
2,278,958
|
$1,033,189,000 | — | 31 Dec 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.89%
|
2,263,732
|
$1,026,286,730 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.87%
|
2,221,953
|
$1,007,381,334 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.85%
|
2,152,672
|
$975,935,404 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.77%
|
1,970,105
|
$893,166,805 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.73%
|
1,859,221
|
$842,896,433 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.7%
|
1,768,881
|
$801,939,888 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.69%
|
1,754,118
|
$795,247,072 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.6%
|
1,527,586
|
$692,546,059 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.51%
|
1,304,161
|
$591,254,430 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.47%
|
1,194,512
|
$541,544,000 | — | 31 Dec 2025 | |
| WCM INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
1,129,145
|
$512,338,252 | — | 31 Dec 2025 | |
| EDGEWOOD MANAGEMENT LLC |
13F
|
Company |
0.42%
|
1,060,075
|
$480,595,602 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.41%
|
1,042,397
|
$472,581,103 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.37%
|
945,660
|
$428,726,296 | — | 31 Dec 2025 | |
| Winslow Capital Management, LLC |
13F
|
Company |
0.35%
|
887,640
|
$405,097,722 | — | 31 Dec 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.33%
|
848,639
|
$384,738,977 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.33%
|
847,758
|
$384,339,567 | — | 31 Dec 2025 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.33%
|
832,853
|
$377,582,236 | — | 31 Dec 2025 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.32%
|
803,773
|
$364,399,701 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.3%
|
752,425
|
$342,202,401 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.29%
|
741,813
|
$336,308,394 | — | 31 Dec 2025 | |
| Swiss National Bank |
13F
|
Company |
0.28%
|
702,600
|
$318,530,736 | — | 31 Dec 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.27%
|
681,120
|
$308,792,563 | — | 31 Dec 2025 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.26%
|
669,807
|
$303,718,000 | — | 31 Dec 2025 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
654,470
|
$296,710,519 | — | 31 Dec 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.25%
|
630,289
|
$285,886,354 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
0.23%
|
593,947
|
$269,271,812 | — | 31 Dec 2025 | |
| Mitsubishi UFJ Asset Management Co., Ltd. |
13F
|
Company |
0.22%
|
566,227
|
$256,008,214 | — | 31 Dec 2025 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2026
As of 31 Mar 2026,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
1,663 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
231,885,243 shares.
The largest 10 holders included
Capital World Investors, BlackRock, Inc., Capital Research Global Investors, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD PORTFOLIO MANAGEMENT LLC, Capital International Investors, and LOOMIS SAYLES & CO L P.
This page lists
1,663
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
1,656
Q1 2026 holders
1,663
Holder diff
7
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.